See the full presentation from Certara’s Biotech Forum, a strategic workshop built to help biotech executives, founders, and R&D leaders develop investor-ready strategies ahead of RESI and JPM Healthcare 2027.
What’s in the presentation
This deck covers the full day of content from Certara’s Biotech Forum, held in partnership with Life Science Nation (LSN), organizers of RESI, including:
- Building a clear value proposition: what investors actually look for in a pitch: a well-defined medical need, genuine differentiation, and the regulatory and commercial foresight to back it up
- Designing a development plan that supports financing and regulatory success: how to build a realistic path from IND to first-in-human that satisfies both regulators and investors
- Selecting the right clinical candidate: what “investor-ready” evidence looks like, from translational relevance to study design and manufacturability
- Corporate factors that shape investor decisions: LSN’s perspective on the factors investors weigh beyond the science
- Future trends in regulatory science: how recent regulatory shifts are changing the way companies need to plan earlier in development
- Preparing for RESI and JPM week: how to prepare before these events, run productive meetings during them, and convert conversations into real momentum after it ends
- [Discussion only] Cross-functional perspectives on early development: perspectives from biotech leaders, investors, pharma, and Certara experts on how early strategic decisions shape risk, speed, and fundability.
This presentation is built for:
- Biotech CEOs, founders, and executive teams preparing for RESI and JPM
- R&D leaders refining development strategy
- Venture and investment professionals evaluating early-stage programs
- Business development teams preparing for partnering meetings
Featuring insights from:
Sougato Das (Life Science Nation), Tony Arulanandam, DVM, PhD (SynaptImmune Therapeutics), Wojciech Dworakowski (Pioneering Medicines), Katya Tsaioun, PhD (Akttyva Therapeutics), Dustin Armstrong, PhD (Parasail LLC), and Certara’s Fran Brown, Maximilian Vargas, Kevin Hershberger, Geoff Fatzinger, Tong Zhu, Diana Marcantonio, John Pennet (Mid Atlantic Bio Angels) and Koji Yasuda (Fast Track Initiative)
Ready to see the full presentation?
Get instant access to the complete deck, covering value proposition development, regulatory-ready planning, clinical candidate selection, and RESI/JPM meeting prep.
Download the presentation
